PLACENTAL CYTOKINES AND PATHOGENESIS OF PREECLAMPSIA
胎盘细胞因子和先兆子痫的发病机制
基本信息
- 批准号:6410480
- 负责人:
- 金额:$ 17.7万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2001
- 资助国家:美国
- 起止时间:2001-01-01 至 2002-06-13
- 项目状态:已结题
- 来源:
- 关键词:clinical research cytokine enzyme linked immunosorbent assay erythropoietin female histology human pregnant subject hypoxia immunocytochemistry interferon gamma interleukin 1 laboratory rat nucleic acid sequence pathologic process placenta preeclampsia tissue /cell culture tumor necrosis factor alpha tumor necrosis factor beta vascular endothelium
项目摘要
Inadequate trophoblast invasion and physiologic remodelling of
spiral arteries initiate focal placental ischemia and hypoxia in
preeclampsia. Placental hypoxia has been implicated in the
production of "toxic" factor(s) by the placenta which circulate
causing maternal disease allegedly by compromising vascular
endothelial function. Trophoblasts and other placental cells
normally produce a variety of cytokines, which are potentially
deleterious to the vascular endothelium. We recently discovered
that trophoblasts and other placental cells also express
erythropoietin (EPO), which is the prototype molecule for
transcriptional regulation by hypoxia. This finding suggests a new
and logical approach to narrowing the search for the "toxic"
factor(s) produced in the placenta by hypoxia during preeclampsia,
that have remained elusive for years. That is, identification of
DNA sequences homologous to the hypoxic responsive-enhancer element
of EPO within the genes encoding various cytokines may provide a
possible link between placental hypoxia and overproduction of these
potentially deleterious factors in preeclampsia. Indeed, our
preliminary experiments show that hypoxia stimulates production of
TNF-alpha and IL-1beta by placental villous explants, and plasma
TNF-alpha is elevated in preeclampsia. An overall goal of this
grant proposal is to investigate whether cytokines are overproduced
by the placenta in response to hypoxia contributing to increased
plasma levels, and thus, endothelial activation and dysfunction in
preeclampsia. Although compelling, the evidence suggesting
endothelial activation and dysfunction in the disease is mainly
circumstantial. Therefore, another goal is to provide direct
evidence for endothelial activation by investigating the expression
of products of cellular activation (consistent with cytokine
stimulation) on the endothelium of blood vessels in skin biopsies,
as well as in branches of inferior epigastric arteries and veins.
Five Hypotheses and Specific Aims, listed under Specific Aims in the
Research Plan, test various aspects of the pathogenesis of
preeclampsia as proposed in the following general schema. Of note,
the etiology of the disease presumably related to deficient
trophoblast invasion is not addressed by this proposal.
DEFICIENT TROPHOBLAST INVASION OF SPIRAL ARTERIES------>FOCAL
PLACENTAL HYPOXIA AIM4>
OVERPRODUCTION OF PLACENTAL CYTOKINES AIM 2 >ELEVATED PLASMA
CYTOKINES
AIMS 1 & 3 >ENDOTHELIAL ACTIVATION AND DYSFUNCTION
AIM5 >DISEASE MANIFESTATIONS
滋养层侵袭不足和生理重塑
螺旋动脉引发局灶性胎盘缺血和缺氧
先兆子痫 胎盘缺氧与
胎盘产生“有毒”因子,
据称通过破坏血管而导致母体疾病
内皮功能 滋养层细胞和其他胎盘细胞
通常会产生多种细胞因子,这些细胞因子可能
对血管内皮有害。 我们最近发现
滋养层和其他胎盘细胞也表达
促红细胞生成素(EPO),这是原型分子,
缺氧的转录调控。 这一发现表明,
和逻辑的方法来缩小搜索“有毒”
在先兆子痫期间由缺氧在胎盘中产生的因子,
多年来一直难以捉摸 也就是说,
与低氧应答增强子元件同源的DNA序列
编码各种细胞因子的基因中EPO的表达可以提供
胎盘缺氧和这些物质的过度产生之间可能存在联系
潜在的有害因素。 的确,我们的
初步实验表明,缺氧刺激产生
胎盘绒毛外植体和血浆中的TNF-α和IL-1 β
TNF-α在先兆子痫中升高。 这一总体目标
一项拨款提案是调查细胞因子是否在
胎盘对缺氧的反应导致
血浆水平,因此,内皮细胞活化和功能障碍,
先兆子痫 尽管很有说服力,但证据表明
内皮激活和功能障碍的疾病主要是
间接证据 因此,另一个目标是提供直接的
通过研究内皮细胞的表达,
细胞活化产物(与细胞因子
刺激)对皮肤活组织检查中血管内皮的作用,
以及腹壁下动脉和静脉的分支。
五个假设和具体目标,列在
研究计划,测试发病机制的各个方面,
先兆子痫,如以下一般图式中所提出的。 值得注意的是,
疾病的病因可能与缺乏
滋养层侵入未被该提议所解决。
螺旋动脉滋养层浸润不足-->局灶性
胎盘缺氧AIM 4>
胎盘细胞因子AIM 2的过度产生>升高的血浆
细胞因子
目标1和3 >内皮激活和功能障碍
目标5>疾病表现
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Kirk P Conrad其他文献
Kirk P Conrad的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Kirk P Conrad', 18)}}的其他基金
Corpus Luteal Contribution to Maternal Pregnancy Physiology and Outcomes in ART
黄体对孕产妇妊娠生理学和 ART 结局的贡献
- 批准号:
8337222 - 财政年份:2011
- 资助金额:
$ 17.7万 - 项目类别:
Corpus Luteal Contribution to Maternal Pregnancy Physiology and Outcomes in ART
黄体对孕产妇妊娠生理学和 ART 结果的贡献
- 批准号:
8730697 - 财政年份:2011
- 资助金额:
$ 17.7万 - 项目类别:
Corpus Luteal Contribution to Maternal Pregnancy Physiology and Outcomes in ART
黄体对孕产妇妊娠生理学和 ART 结果的贡献
- 批准号:
8509741 - 财政年份:2011
- 资助金额:
$ 17.7万 - 项目类别:
Corpus Luteal Contribution to Maternal Pregnancy Physiology and Outcomes in ART
黄体对孕产妇妊娠生理学和 ART 结局的贡献
- 批准号:
8151717 - 财政年份:2011
- 资助金额:
$ 17.7万 - 项目类别:
Corpus Luteal Contribution to Maternal Pregnancy Physiology and Outcomes in ART
黄体对孕产妇妊娠生理学和 ART 结局的贡献
- 批准号:
9058150 - 财政年份:2011
- 资助金额:
$ 17.7万 - 项目类别:
Relaxin: The 'Elusive' Vasodilator of Pregnancy
松弛素:“难以捉摸”的妊娠血管扩张剂
- 批准号:
6703795 - 财政年份:2001
- 资助金额:
$ 17.7万 - 项目类别:
Endogenous Relaxin Regulates Vascular Function in Nonpregnant Females and Males
内源性松弛素调节非妊娠女性和男性的血管功能
- 批准号:
7388841 - 财政年份:2001
- 资助金额:
$ 17.7万 - 项目类别:
Endogenous Relaxin Regulates Vascular Function in Nonpregnant Females and Males
内源性松弛素调节非妊娠女性和男性的血管功能
- 批准号:
7252878 - 财政年份:2001
- 资助金额:
$ 17.7万 - 项目类别:
相似海外基金
Development of platform for non-invasive, rapid, and simple analysis of cytokine secretion from single cells
开发非侵入、快速、简单分析单细胞细胞因子分泌的平台
- 批准号:
23H01824 - 财政年份:2023
- 资助金额:
$ 17.7万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Therapeutic approach to confer an anti-tumorigenic role of IL-6 to the pro-tumorigenic cytokine in effector T cells
赋予效应T细胞中促肿瘤细胞因子IL-6抗肿瘤作用的治疗方法
- 批准号:
23K06723 - 财政年份:2023
- 资助金额:
$ 17.7万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Diversity of haematopoietic cytokine receptor activation exploring with marine probes
用海洋探针探索造血细胞因子受体激活的多样性
- 批准号:
23K14019 - 财政年份:2023
- 资助金额:
$ 17.7万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
A point-of-care salivary cytokine test for early detection of oral cancer
用于早期发现口腔癌的即时唾液细胞因子检测
- 批准号:
10760626 - 财政年份:2023
- 资助金额:
$ 17.7万 - 项目类别:
Development of Coccidioides Cytokine Release Assay
球孢子菌细胞因子释放测定的发展
- 批准号:
10760131 - 财政年份:2023
- 资助金额:
$ 17.7万 - 项目类别:
Combinatorial cytokine-coated macrophages for targeted immunomodulation in acute lung injury
组合细胞因子包被的巨噬细胞用于急性肺损伤的靶向免疫调节
- 批准号:
10648387 - 财政年份:2023
- 资助金额:
$ 17.7万 - 项目类别:
FOXA1 regulates cytokine signaling and immune landscape in prostate cancer through ARID1A
FOXA1 通过 ARID1A 调节前列腺癌中的细胞因子信号传导和免疫景观
- 批准号:
10681898 - 财政年份:2023
- 资助金额:
$ 17.7万 - 项目类别:
Cytokine Regulation of Secondary Neural Progenitors
次级神经祖细胞的细胞因子调节
- 批准号:
10752901 - 财政年份:2023
- 资助金额:
$ 17.7万 - 项目类别:
Generating a novel conditional knockout mouse for a super-enhancer that controls cytokine responsiveness
生成一种新型条件敲除小鼠,用于控制细胞因子反应的超级增强子
- 批准号:
10740932 - 财政年份:2023
- 资助金额:
$ 17.7万 - 项目类别:
Cytokine receptor common beta chain alterations in mediastinal lymphomas
纵隔淋巴瘤细胞因子受体常见β链改变
- 批准号:
489197 - 财政年份:2023
- 资助金额:
$ 17.7万 - 项目类别:
Operating Grants